These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35307577)

  • 41. Hürthle cell-predominant thyroid fine needle aspiration cytology: A four risk-factor model highly accurate in excluding malignancy and predicting neoplasm.
    Yuan L; Nasr C; Bena JF; Elsheikh TM
    Diagn Cytopathol; 2022 Sep; 50(9):424-435. PubMed ID: 35674254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
    Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
    Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of cytological subclassification of thyroid nodules with Bethesda category III cytology (AUS/FLUS) into architectural atypia only and nuclear atypia: A prospective study.
    Rosario PW; Calsolari MR
    Diagn Cytopathol; 2017 Jul; 45(7):604-607. PubMed ID: 28425211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.
    Gomes-Lima CJ; Auh S; Thakur S; Zemskova M; Cochran C; Merkel R; Filie AC; Raffeld M; Patel SB; Xi L; Wartofsky L; Burman KD; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2020; 11():53. PubMed ID: 32132976
    [No Abstract]   [Full Text] [Related]  

  • 45. Both Ultrasound Features and Nuclear Atypia are Associated with Malignancy in Thyroid Nodules with Atypia of Undetermined Significance.
    Eisa N; Khan A; Akhter M; Fensterwald M; Saleem S; Fananapazir G; Campbell MJ
    Ann Surg Oncol; 2018 Dec; 25(13):3913-3918. PubMed ID: 30302643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.
    Choi YJ; Baek JH; Ha EJ; Lim HK; Lee JH; Kim JK; Song DE; Shong YK; Hong SJ
    Thyroid; 2014 Mar; 24(3):494-501. PubMed ID: 23947771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
    Yaprak Bayrak B; Eruyar AT
    BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between Tsukuba elasticity scores 4 and 5 on elastography and Bethesda undetermined cytology on US-guided FNA with 27-G needle, verified by histopathology: a cut-off point of 20 mm of diameter designated for thyroid nodules.
    Sengul D; Sengul I
    J BUON; 2019; 24(1):382-390. PubMed ID: 30941995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequencies and malignancy rates of 6-tiered Bethesda categories of thyroid nodules according to ultrasound assessment and nodule size.
    Park VY; Lee HS; Kim EK; Kwak JY; Yoon JH; Moon HJ
    Head Neck; 2018 Sep; 40(9):1947-1954. PubMed ID: 29684254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
    Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
    Ha EJ; Baek JH; Lee JH; Song DE; Kim JK; Shong YK; Hong SJ
    Thyroid; 2013 Jun; 23(6):703-8. PubMed ID: 23544697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low Malignancy Rates in Fine-Needle Aspiration Cytologies in a Primary Care Setting in Germany.
    Eszlinger M; Ullmann M; Ruschenburg I; Böhme K; Görke F; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Paschke R
    Thyroid; 2017 Nov; 27(11):1385-1392. PubMed ID: 28982301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of the 2015 American Thyroid Association Management Guidelines for Thyroid Nodules With Benign Cytologic Findings in the Era of the Bethesda System.
    Kim YY; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
    AJR Am J Roentgenol; 2018 Mar; 210(3):629-634. PubMed ID: 29323546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elastosonography scoring and strain index of thyroid nodules with Hurthle cells.
    Tuzun D; Ersoy R; Kilicyazgan A; Kiyak G; Yalcin S; Cakir B
    Minerva Endocrinol; 2016 Jun; 41(2):157-65. PubMed ID: 25310014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of malignancy in patients with a thyroid nodule that contains Hürthle cells.
    Turanli S; Pirhan Y; Ozcelik CK; Cetin A
    Otolaryngol Head Neck Surg; 2011 Apr; 144(4):514-7. PubMed ID: 21493226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules.
    Larcher de Almeida AM; Delfim RLC; Vidal APA; Chaves MCDCM; Santiago ACL; Gianotti MF; Gonçalves MDDC; Vaisman M; de Carvalho DP; Teixeira PFDS
    Thyroid; 2021 Jun; 31(6):922-932. PubMed ID: 33143569
    [No Abstract]   [Full Text] [Related]  

  • 57. Assessment of malignancy rate in thyroid nodules according to the Bethesda system of fine-needle aspiration. Report from a tertiary center in the Southwestern region of Saudi Arabia.
    Al-Shraim MM; Kaood OM; Hussein MR; Al-Ahmary AM; Al Shehri GY; Jastania RA; Mahfouz AA; Abu-Eshy SA
    Saudi Med J; 2012 Feb; 33(2):167-71. PubMed ID: 22327757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can Cytologic and Sonographic Features Help Prevent Overtreatment of Bethesda V Thyroid Nodules?
    Higgins S; James BC; Sacks B; Mowschenson P; Nishino M; Hasselgren PO
    J Surg Res; 2021 Dec; 268():112-118. PubMed ID: 34298210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Additional BRAF mutation analysis may have additional diagnostic value in thyroid nodules with "suspicious for malignant" cytology alone even when the nodules do not show suspicious US features.
    Seo JY; Kim EK; Kwak JY
    Endocrine; 2014 Sep; 47(1):283-9. PubMed ID: 24452872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience.
    Xavier-Júnior JCC; Abrantkoski Borges F; Pizzello Zogheib RJ; Camilo-Júnior DJ
    Acta Cytol; 2021; 65(1):22-26. PubMed ID: 32877898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.